Is There a Clinical Benefit of Abdominal Binders After Abdominal Surgery: A Systematic Literature Review

J Abdom Wall Surg. 2024 Oct 17:3:13506. doi: 10.3389/jaws.2024.13506. eCollection 2024.

Abstract

Background: The incidence of incisional hernia following laparotomy varies between 2% and 30%. It is well-established that the need to control several risk factors prior to surgery exists (weight loss before surgery, diabetes control). Postoperative abdominal binder (AB) is often recommended by surgeons, yet evidence on this topic is lacking. The aim of this review was to present current evidence on the use of abdominal binders after abdominal surgery.

Material and methods: A comprehensive literature review between January and May 2024 was conducted using a range of search engines, including PubMed, Science Direct, EMBASE, Google Scholar, and Google. The following keywords were used: "abdominal binder," "abdominal support," "hernia," "girdle and hernia," "compression belt and hernia," and "abdominal support and hernia."

Results: Sixteen articles were selected for further analysis (7 RCTs, 6 non-RCTs and 3 meta-analyses). None of the studies reported a reduction in the incidence of abdominal dehiscence or incisional hernia. Postoperative use of the AB has been shown to reduce postoperative discomfort and pain for a limited period of up to 48-72 h. There was no discernible difference in the incidence of surgical site complications.

Conclusion: The current evidence indicates that the use of AB following abdominal surgery is safe, although no benefit has been established (except 48 h after surgery). AB may enhance comfort in select patients; however, further studies are necessary to justify their routine use, with a particular focus on the medical and economic implications.

Keywords: abdominal binders; abdominal surgery; laparotomy; postoperative complications; postoperative pain.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study was funded by the Tourangelle Association for Research in Oncology in the Loire Valley (AT-ROVL), Tours, France.